Cargando…
COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature
Myasthenia gravis (MG) is a rare autoimmune disease that is potentially threatening for patient life. Auto-antibodies targeting structures of the neuromuscular junction, particularly the acetylcholine receptor (AchR), are often found in the serum of MG patients. New-onset MG after SARS-CoV-2 vaccina...
Autores principales: | Virgilio, Eleonora, Tondo, Giacomo, Montabone, Claudia, Comi, Cristoforo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819717/ https://www.ncbi.nlm.nih.gov/pubmed/36612789 http://dx.doi.org/10.3390/ijerph20010467 |
Ejemplares similares
-
Safety of COVID-19 Vaccines: Spotlight on Neurological Complications
por: Tondo, Giacomo, et al.
Publicado: (2022) -
New-Onset Myasthenia Gravis Following COVID-19 Vaccination
por: Özenç, Betül, et al.
Publicado: (2022) -
Late-onset myasthenia gravis is predisposed to become generalized in the elderly
por: Sakai, Waka, et al.
Publicado: (2016) -
Outcome measures and treatment effectiveness in late onset myasthenia gravis
por: Pasqualin, Francesca, et al.
Publicado: (2020) -
Early-Onset Myasthenia Gravis Following COVID-19 Vaccination
por: Lee, Myung Ah, et al.
Publicado: (2022)